Skip to main content
TIANYU BIO-TECHNOLOGY CO.,LTD. logo

TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings

Ticker · 603717 ISIN · CNE1000030W1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2024-12-18 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603717

About TIANYU BIO-TECHNOLOGY CO.,LTD.

https://www.tianyubiotech.com/

TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.

Recent filings

Filing Released Lang Actions
控股股东、实际控制人关于《天域生物科技股份有限公司股票交易异常波动的问询函》的回复
Regulatory Filings
2024-12-18 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Tianyu Bio-Technology Co., Ltd. regarding abnormal stock price fluctuations over three consecutive trading days in December 2024. It includes the company's investigation results confirming no undisclosed material information affecting the stock price, a risk warning to investors, and a statement from the board of directors. The content focuses on stock trading irregularities and related disclosures rather than financial results, management changes, or other report types. This matches the characteristics of a Regulatory Filing (RNS) as it is a regulatory announcement about stock price abnormality and compliance with exchange rules, not a financial report or other specific filing type.
2024-12-18 Chinese
关于公司2024年度对外担保预计的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Tianyu Bio-Technology Co., Ltd. regarding the progress of external guarantees for the year 2024. It details the guarantee amounts, the parties involved, financial data of the guaranteed subsidiaries, and board meeting approvals related to these guarantees. The document is relatively short (3550 characters) and focuses on a specific financial update about guarantees rather than a comprehensive financial report or audit. It does not contain full financial statements or detailed financial analysis typical of annual or interim reports. It is also not a certification, call transcript, or legal proceeding report. The content fits best with a regulatory announcement about financing or capital structure updates, specifically about guarantees provided by the company and its subsidiaries. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-12-17 Chinese
关于变更证券事务代表的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the change of the company's securities affairs representative, including the retirement of the previous representative and the appointment of a new one. It contains no financial data, no report or financial results, and no mention of any meeting results or voting. It is a management-related announcement about personnel changes but not about board or senior management changes. The closest category is Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2024-12-17 Chinese
中德证券有限责任公司关于天域生物科技股份有限公司部分募投项目延期的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from a sponsoring securities company regarding the delay of certain fundraising investment projects by Tianyu Biotechnology Co., Ltd. It discusses the use and management of raised funds, project delays, board and supervisory approvals, and regulatory compliance. The document includes financial figures related to fundraising and investment progress but does not present a full financial report or comprehensive financial statements. It is a specialized audit or verification report related to fundraising project delays, not a full annual or interim report. The document length is 3417 characters, which is relatively short but contains substantive content beyond a mere announcement. It fits best under the category of Audit Report / Information (AR), as it is a standalone audit/verification report on fundraising project delays and compliance, rather than a full annual report or other categories. 9M 2024
2024-12-17 Chinese
关于部分募投项目延期的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a company regarding the delay of a capital investment project funded by previously raised funds. It details the extension of the project completion date, reasons for the delay, risk factors, and approvals by the board and supervisory committee. The document references the use of raised funds and compliance with regulatory requirements but does not contain financial statements or detailed financial performance data. It is a regulatory announcement about a capital project update, specifically about the postponement of a fundraising investment project. This fits the category of Capital/Financing Update (CAP) rather than a full financial report or audit report. The document length is about 4976 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the correct classification is CAP with high confidence.
2024-12-17 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.